Empirical Finance’s AbbVie ABBV Stock Holding History

Empirical Finance’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$11.4M	Buy	61,266 +391	+0.6%	+$72.6K	0.6%	27
2025 Q1	$12.8M	Buy	60,875 +727	+1%	+$152K	0.77%	25
2024 Q4	$10.7M	Sell	60,148 -790	-1%	-$140K	0.62%	28
2024 Q3	$12M	Buy	60,938 +1,303	+2%	+$257K	0.7%	25
2024 Q2	$10.2M	Sell	59,635 -4,037	-6%	-$692K	0.64%	26
2024 Q1	$11.6M	Buy	63,672 +2,138	+3%	+$389K	0.71%	26
2023 Q4	$9.54M	Buy	61,534 +364	+0.6%	+$56.4K	0.67%	27
2023 Q3	$9.12M	Buy	61,170 +5,936	+11%	+$885K	0.67%	28
2023 Q2	$7.44M	Buy	55,234 +6,140	+13%	+$827K	0.58%	31
2023 Q1	$7.82M	Buy	49,094 +2,917	+6%	+$465K	0.73%	24
2022 Q4	$7.46M	Buy	46,177 +3,817	+9%	+$617K	0.77%	26
2022 Q3	$5.69M	Buy	42,360 +6,838	+19%	+$918K	0.67%	27
2022 Q2	$5.44M	Buy	35,522 +1,920	+6%	+$294K	0.69%	27
2022 Q1	$5.45M	Buy	33,602 +3,714	+12%	+$602K	0.61%	28
2021 Q4	$4.05M	Buy	29,888 +8,161	+38%	+$1.11M	0.48%	37
2021 Q3	$2.34M	Buy	21,727 +1,286	+6%	+$139K	0.35%	53
2021 Q2	$2.3M	Buy	20,441 +2,941	+17%	+$331K	0.38%	50
2021 Q1	$1.88M	Hold	17,500	–	–	0.33%	82
2020 Q4	$1.88M	Buy	17,500 +3,164	+22%	+$339K	0.33%	82
2020 Q3	$1.26M	Sell	14,336 -12,171	-46%	-$1.07M	0.27%	96
2020 Q2	$2.6M	Buy	26,507 +1,749	+7%	+$172K	0.67%	24
2020 Q1	$1.89M	Buy	24,758 +3,088	+14%	+$235K	0.59%	30
2019 Q4	$1.92M	Sell	21,670 -2,142	-9%	-$190K	0.47%	29
2019 Q3	$1.8M	Buy	23,812 +20,250	+569%	+$1.53M	0.5%	31
2019 Q2	$259K	Sell	3,562 -71	-2%	-$5.16K	0.07%	141
2019 Q1	$293K	Buy	3,633 +831	+30%	+$67K	0.07%	138
2018 Q4	$258K	Sell	2,802 -232	-8%	-$21.4K	0.08%	130
2018 Q3	$287K	Buy	3,034 +329	+12%	+$31.1K	0.07%	125
2018 Q2	$251K	Sell	2,705 -928	-26%	-$86.1K	0.06%	121
2018 Q1	$293K	Buy	+3,633	New	+$293K	0.07%	138
2017 Q4	–	Sell	-3,388	Closed	-$302K	–	97
2017 Q3	$302K	Buy	+3,388	New	+$302K	0.1%	105
2017 Q1	–	Sell	-703	Closed	-$45K	–	86
2016 Q4	$45K	Buy	+703	New	+$45K	0.03%	111